Public Company News
Positive Profit Alert: Expecting a Profit Attributable to Owners of 6.4-7.7x of FY2019/20, Reaching c. HK$70-85 million
HONG KONG, May 25, 2021 /PRNewswire/ -- A specialist in design, manufacturing and Internet of Things ("IoT") solutions in the electronics manufacturing services industry –Computime Group Limited ("Computime" or the "Company", together with its subsidiaries the "Group", stock code: 320.HK) is plea...
2021-05-25 11:11
4895
FIMER to Power Asia's First Automatic Frequency Control Initiative
* FIMER has partnered with Taiwan Stock Exchange (TSE)-listed smart energy conglomerate Tatung (Tatung:2371) to supply battery energy storage systems (BESS) for Taiwan Power Company (Taipower)'s automatic frequency control (AFC) initiative. * FIMER will supply its PVS980-58BC bidirectional ...
2021-05-25 09:00
3180
PayMyTuition Supports Strategic Expansion in China with Selection of Fiserv to Enable Local Payment Methods for Overseas Services
SHANGHAI, May 25, 2021 /PRNewswire/ -- PayMyTuition, a leading provider of technology-driven global payment processing solutions for tuition payments, is supporting a strategic expansion inChina with the selection of Fiserv to facilitate tuition payments for Chinese students attending colleges...
2021-05-25 08:30
5620
Clinical Trial Application of ASC40 Combined with Bevacizumab to Treat Patients with Recurrent Glioblastoma Accepted by China NMPA
HANGZHOU and SHAOXING, China, May 25, 2021 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX code: 1672) today announces that following the consultation with China National Medical Products Administration (NMPA), the clinical trial application of ASC40 combined with bevacizumab to treat patients with re...
2021-05-25 08:30
3840
Innovent Announces First Patient Dosed in China in the Global Phase 3 Clinical Trial of Pemigatinib as the First-line Treatment of Unresectable or Metastatic Cholangiocarcinoma
SAN FRANCISCO and SUZHOU, China, May 25, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune and other major dis...
2021-05-25 08:00
12161
Antengene Appoints Kathryn Gregory as Vice President and Head of Corporate Business Development
SHANGHAI and HARTFORD, Conn., May 25, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics in hematology and...
2021-05-25 08:00
4899
CLPS Incorporation Announces Strategic Cooperation with MCT, a Hong Kong Listed Company, to Develop a Next Generation Loan Trading Software
HONG KONG, May 24, 2021 /PRNewswire/ -- CLPS Incorporation (Nasdaq: CLPS) ("CLPS" or "the Company"), today announced a strategic cooperation with Minshang Creative Technology Holdings Limited ("MCT", 01632.HK) to jointly develop a next generation loan trading software and to explore global financ...
2021-05-24 20:30
7321
Biovaxys Strengthens Internal Expertise With Appointment Of Scientific Advisor For Ovarian Cancer Vaccine Clinical Program And Papilocare Marketing
VANCOUVER, British Columbia, May 24, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV, FRA: 5LB, US OTCQB: BVAXF) ("BioVaxys" or "the Company") is pleased to announce thatCharles J. Dunton, MD, has joined BioVaxys as an Advisor to help provide additional scientific support for BVX-0918A,...
2021-05-24 20:00
7960
Ping An Supports Global Poverty Alleviation, Taking Successful China Handicraft Project to Cambodia
HONG KONG and SHANGHAI, May 24, 2021 /PRNewswire/ -- Ping An Insurance (Group) Company ofChina, Ltd. (hereafter "Ping An" or the "Group", HKEX: 2318; SSE: 601318) announced a new poverty alleviation program forCambodia at the International Forum on Poverty Governance and Development Towards Moder...
2021-05-24 19:34
15416
Akeso's Penpulimab Monoclonal Antibody Submitted BLA in the United States
HONG KONG, May 24, 2021 /PRNewswire/ -- On May 24, 2021, Akeso, Inc. (HKEx: 9926.HK) announced that Penpulimab (research and development code: AK105), an PD-1 monoclonal antibody drug co-developed by the Company with Sino Biopharmaceutical Limited (HKEx: 1177.HK), has submitted a Biologics Licens...
2021-05-24 18:17
3675
CanSinoBIO Receives European GMP Certification for its COVID-19 Vaccine Convidecia™
* A major step for introducing Convidecia™ to more countries and people in need for protection * Vaccine has been approved in China, Mexico, Pakistan, Hungary and Chile * Provides timely clinical protection for adults aged 18 and above, including those over 60 TIANJIN, China, May 24, 2021 /P...
2021-05-24 17:00
6729
Daewoong, first-in-class PRS-inhibitor for Idiopathic Pulmonary Fibrosis (IPF) shows promising result in early stage clinical test
* We confirmed the safety of 'DWN12088' and secured grounds for establishing treatment dosage * Confirming the potential as a treatment for IPF and planning to apply for Ph.2 within 2021 * 2nd ODD granted as treatment for systemic sclerosis from the US FDA SEOUL, South Korea, May 24, 2021 /...
2021-05-24 16:59
2257
Kuaishou Technology Announces First Quarter 2021 Unaudited Financial Results
HONG KONG, May 24, 2021 /PRNewswire/ -- Kuaishou Technology (HK:1024) (the "Company" or "Kuaishou"), a leading content community and social platform, today announced its unaudited consolidated results for the first quarter of 2021 endedMarch 31, 2021 ("1Q2021"). First Quarter 2021 Key Financial ...
2021-05-24 16:50
14253
Sonata Software celebrates 30 years of relationship with Microsoft
- To further expand the relationship with a range of new growth initiatives and investments aligned to Microsoft strategy BANGALORE, India, May 24, 2021 /PRNewswire/ -- Sonata Software Ltd., a global IT services and technology solutions company, announced 30 years of relationship with Microsoft,...
2021-05-24 16:20
6005
Ericsson updates risk factors for Euro corporate bond prospectus
STOCKHOLM, May 24, 2021 /PRNewswire/ -- As previously disclosed by Ericsson (NASDAQ: ERIC) in its Q4 2020 financial report and in its 2020 annual report, there is a risk that the decision by the Post and Telecommunication Authority (PTS) to exclude Chinese vendors' products from the 5G auction in...
2021-05-24 15:21
5623
iQIYI Launches its "SWEET ON Theater" Romantic Drama Collection
BEIJING, May 24, 2021 /PRNewswire/ -- iQIYI Inc. (NASDAQ: IQ) ("iQIYI" or the "Company"), an innovative market-leading online entertainment service inChina, is pleased to announce that it has released the first series of its "SWEET ON Theater", a new collection of romantic dramas. The first serie...
2021-05-24 14:45
6120
Seegene introduces an exclusive diagnostic system for diagnosing COVID-19 variants at ECCMID
SEOUL, Korea, May 24, 2021 /PRNewswire/ -- Seegene Inc. (KQ 096530), a biotechnology firm specializing in molecular diagnostics has once again been recognized for its unique system for diagnosing COVID-19 variants at this year's European Congress of Clinical Microbiology, the ECCMID. Seegene's...
2021-05-24 09:58
2281
Payment security is key as Asia Pacific resets digital commerce in post-pandemic world
SINGAPORE, May 24, 2021 /PRNewswire/ -- Visa, the leader in digital payments, has set its focus on strengthening payments security as consumer behaviour evolves during the pandemic. Addressing more than 1,500 partners and clients in its first virtual edition of the Asia Pacific Visa Security Summ...
2021-05-24 09:10
8254
Poster to Highlight ENVASARC Pivotal Trial of Envafolimab (KN035) will be presented at the 2021 ASCO Annual Meeting
SUZHOU, China, May 24, 2021 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced the study design of the ENVASARC pivotal trial in the U.S. of Envafolimab (KN035), a recombinant humanized PD-L1 single domain antibody independently invented by Alphamab Oncology, will be presented by A...
2021-05-24 08:54
6683
Novavax Announces Memorandum of Understanding to Explore Expansion of COVID-19 Vaccine Activities in South Korea
Novavax and SK bioscience reaffirm partnership during meeting with South Korean leaders GAITHERSBURG, Md., May 23, 2021 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced the signing of a non-...
2021-05-23 00:39
10095
Week's Top Stories
Most Reposted
Agoda Makes it Easier for Travelers to See Relevant Photos in Reviews
[Picked up by 313 media titles]
2026-05-06 12:00
Tonik Becomes the First Standalone Digital Bank in the Philippines to Achieve Profitability
[Picked up by 295 media titles]
2026-05-12 10:15
Visa amps up the music as Official Payment Partner for the Asia leg of The Weeknd's 'After Hours Til Dawn' Stadium Tour
[Picked up by 293 media titles]
2026-05-11 16:20
Avnet and HKSTP Invite Global Startups to New AI Hardware Launchpad
[Picked up by 288 media titles]
2026-05-12 10:00Peach Blossoms Celebrates Three Massive Wins - Black Pearl Restaurant Guide 2026, Asia's 50 Best Restaurants 2026 Extended List and Tatler Best 20 Restaurants in Singapore 2026
[Picked up by 279 media titles]
2026-05-12 14:00
Most Read
Amadeus delivers solid Q1 2026 growth, and maintains commercial momentum
2026-05-08 18:30
7743
LightInTheBox to Report First Quarter 2026 Financial Results on Tuesday, May 12, 2026
2026-05-06 20:00
7169
Massimo Group Launches Sentinel 770 HVAC as Part of Sentinel Product Line Targeting Approximately US$10 Million in 2026 Revenue
2026-05-06 21:20
7124
NYSE Content Update: HawkEye 360 to Start Trading after its $416 Million IPO
2026-05-07 21:35
6377
Pony.ai Labor Day Holiday Robotaxi Paid Orders Surge More Than Sixfold
2026-05-08 20:00
6186